ReviewNature reviews. Microbiology2026
Human herpesvirus evasion of humoral immunity and implications for vaccine development.
Review in Nature reviews. Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Why do we have a vaccine for measles, but not cytomegalovirus (CMV)?PLoS pathogens · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Herpesviruses are highly species-specific, having co-evolved with their respective hosts over millennia. This evolutionary relationship has led to the development of highly specialized immune evasion strategies, enabling these viruses to establish lifelong infections. Periods of immunosuppression can lead to severe disease, such as graft rejection, cancer, neurodegenerative disease and autoimmune diseases, which have been linked to herpesvirus infections. Consequently, developing strategies to prevent herpesvirus-associated diseases is a critical public health priority. However, varicella zoster virus (VZV) remains the only human herpesvirus for which licensed vaccines are available. This Review explores the mechanisms of humoral immune evasion by herpesviruses and their implications for advancing immunization and treatment strategies for chronic neurological, oncological and transplant-associated diseases caused by these common viral pathogens.
Indexed as
Identifiers
41826436What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.